La infección del sistema de marcapasos es una complicación grave e incluso letal. Se analizan las infecciones del sistema y las formas recomendadas de tratamiento.
La extracción del sistema y fundamentalmente del electrodo roto o infectado plantea problemas técnicos. En ciertos casos pueden extraerse los electrodos por vía percutánea, si bien en diversas circunstancias es obligado el acceso quirúrgico.
Puede ser necesario en ocasiones, por agotamiento de las posibilidades de acceso convencional a los electrodos, el uso de una vía alternativa de implante de marcapasos permanente. Como posibilidad alternativa al implante epicárdico se ha usado la vía femoral para la estimulación permanente.
Palabras clave
Infecciones del marcapasos
Extracción de electrodos
Estimulación permanente vía femoral
Este artículo solo puede leerse en
pdf
Bibliografía
[1.]
J.D. Chua, B.L. Wilkoff, I. Lee, N. Juratli, D.L. Longworth, S.M. Gordon.
Diagnosis and management of infections involving implantable electrophysiologic cardiac devices.
Ann Intern Med, (2000), 133 pp. 604-608
[2.]
A.W. Karchmer.
Infections of Prosthetic valves and Intravascular Devices.
5.ª ed., Churchill Livingstone, pp. 903-917
[3.]
C.P. Craig.
Long-term suppression of foreign body endocarditis with cephalexin.
Am Heart J, (1972), 84 pp. 714-715
[4.]
B.A. Beeler.
Infections of permanent transvenous and epicardial pacemakers in adults.
Heart Lung, (1982), 11 pp. 152
[5.]
G.L. Bluhm.
Pacemaker infections. A 2-year follow-up of antibiotic prophylaxis.
Scand J Thorac Cardiovasc Surg, (1985), 19 pp. 231-235
[6.]
F.M. Grogler, G. Frank, G. Greven, D. Dragojevic, H. Oelert, K. Leitz, et al.
Complications of permanent transvenous cardiac pacing.
J Thorac Cardiovasc Surg, (1975), 69 pp. 895-904
[7.]
T.S. Heimberger, R.J. Duma.
Infections of prosthetic heart valves and cardiac pacemakers.
Infect Dis Clin North Am, (1989), 3 pp. 221-245
[8.]
D. Klug, F. Wallet, S. Kacet, R.J. Courcol.
Detailed bacteriologic tests to identify the origin of transvenous pacing system infections indicate a high prevalence of multiple organisms.
Am Heart J, (2005), 149 pp. 322-328
[9.]
D. Klug, D. Lacroix, C. Savoye, L. Goullard, D. Grandmougin, J.L. Hennequin, et al.
Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management.
Circulation, (1997), 95 pp. 2098-2107
[10.]
M.I. Cohen, D.M. Bush, J.W. Gaynor, V.L. Vetter, R.E. Tanel, L.A. Rhodes.
Pediatric pacemaker infections: Twenty years of experience.
J Thorac Cardiovasc Surg, (2002), 124 pp. 821-827
[11.]
K.K. Lai, S.A. Fontecchio.
Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: epidemiology, infection control, and management.
Clin In- fect Dis, (1998), 27 pp. 265-269
[12.]
M.R. Gold, R.W. Peters, J.W. Johnson, S.R. Shorofsky.
Complications associated with pectoral implantation of cardioverter defibrillators. World-Wide Jewel Investigators.
Pacing Clin Electrophysiol, (1997), 20 pp. 208-211
[13.]
N. Arber, E. Pras, Y. Copperman, J.M. Schapiro, V. Meiner, I.S. Lossos, et al.
Pacemaker endocarditis. Report of 44 cases and review of the literature.
Medicine (Baltimore), (1994), 73 pp. 299-305
[14.]
P. Cacoub, P. Leprince, P. Nataf, P. Hausfater, R. Dorent, B. Wechsler, et al.
Pacemaker infective endocarditis.
Am J Cardiol, (1998), 82 pp. 480-484
[15.]
A.L. Chamis, G.E. Peterson, C.H. Cabell, G.R. Corey, R.A. Sorrentino, R.A. Greenfield, et al.
Staphylococcus aureus bacteremia in patients with permanent pacemakers or or implantable cardioverter-defibrillators.
Circulation, (2001), 104 pp. 1029-1033
[16.]
C. Camus, C. Leport, F. Raffi, C. Michelet, F. Cartier, J.L. Vilde.
Sustained bacteremia in 26 patients with a permanent endocardial pace-maker: assessment of wire removal.
Clin Infect Dis, (1993), 17 pp. 46-55
[17.]
S.A. Spinler, J.J. Nawarskas, E.F. Foote, D. Sabapathi, J.E. Connors, F.E. Marchlinski.
Clinical presentation and analysis of risk factors for infectious complications of implantable cardioverter-defibrillator implantations at a university medical center.
Clin Infect Dis, (1998), 26 pp. 1111-1116
[18.]
D.T. Durack, A.S. Lukes, D.K. Bright.
New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service.
Am J Med, (1994), 96 pp. 200-209
[19.]
Ch.L. Byrd, B.L. Wilkoff, Ch.J. Love, T.D. Sellers, K.T. Turk, R. Reeves, et al.
Intravascular extraction of problematic or infected permanent pacemaker leads.
Pacing Clin Electrophysiol, (1999), 22 pp. 1384-1457
[20.]
C.J. Love, B.L. Wilkoff, C.L. Byrd, P.H. Belott, J.A. Brinker, N.E. Fearnot, et al.
Recomendations for extraction of chronically implanted transvenous pacing and defibrillator leads: Indications, facilities, training.
Pacing Clin Electrophysiol, (2000), 23 pp. 544-551
[21.]
F.A. Bracke, A. Meijer, L.M. Van Gelder.
Pacemaker lead complications: When is extraction appropiate and what can we learn from published data?.
Heart, (2001), 85 pp. 254-259
[22.]
D.M. Gillian, D. Dan.
Excimer laser for pacemakers and defibrillator lead extraction: techniques and clinical results.
Lasers Ned Sci, (2001), 16 pp. 113-121
[23.]
J.F. Roux, P. Pagé, M. Dubuc, B. Thibault, P.G. Guerra, L. Macle, et al.
Laser lead extraction: Predictors of success and complications.
Pacing Clin Electrophysiol, (2007), 30 pp. 214-220
[24.]
Á. Böhm, A. Pintér, G. Duray, D. Lehoczky, G. Dudás, I. Tomcsányi, et al.
Complications due to abandoned noninfected pacemaker leads.
Pacing Clin Electrophysiol, (2001), 24 pp. 1721-1724
[25.]
S. Furman, M. Behrens, C. Andrews.
Retained pacemaker leads.
J Thorac Cardiovasc Surg, (1987), 94 pp. 770-772
[26.]
G. Parry, J.A. Goudevenos, S. Jameson.
Complications associated with retained pacemaker leads.
Pacing Clin Electrophysiol, (1991), 14 pp. 1251-1257
[27.]
G.W. Laub, A.H. Olivencia-Yurbati, S. Muralidharan, D. Morse, S.B. Pollock, M. Adkins, et al.
Permanent transfemoral pacemaker insertion after repair of congenital heart disease.
Ann Thorac Surg, (1991), 52 pp. 148-150
[28.]
H.A. Mazzetti, A. Dussaut, M.C. Tentori, E. Dussaut, J.O. Lazzari.
Unusual placement of a pacemaker pocket.
Pace, (1997), 20 pp. 1739-1740
[29.]
V. Parsonnet, A. Cheema.
An alternate site for pacemaker place- ment when standard locations are not available.
Pace, (2004), 27 pp. 399-400
[30.]
M. El Gamal, B. Van Gelder.
Preliminary experience with the Helifix electrode for transvenous atrial implantation.
Pace, (1979), 2 pp. 444-454
[31.]
S. Villalba, J. Roda, J. Todolí, C. Zaragoza, F. Ridocci, J.V. Vilar.
La vía femoral: una alternativa de excepción para el implante de marcapasos definitivos.
Rev Esp Cardiol, (1994), 47 pp. 490-492
[32.]
J.L. Leal del Ojo, C. Delgado Jiménez, P. Jiménez Vilches.
Absence of the superior vena cava: difficulties for pacemaker implantation.
Pace, (1999), 22 pp. 1103-1105
[33.]
M.H. Ellestad, J. French.
Iliac vein approach to permanent pacemaker implantation.
Pace, (1989), 12 pp. 1030-1033
[34.]
G. Mathur, R.H. Stables, D. Heaven, A. Ingram, R. Sutton.
Permanent pacemaker implantation via the femoral vein: an alternative in cases with contraindications to the pectoral approach.
Europace, (2001), 3 pp. 56-59
[35.]
J.J. García Guerrero, J. Fernández de la Concha Castañeda, G. Fernández Mora, D. López Quero, A. Redondo Méndez, E. Dávila Dávila, et al.
Permanent transfemoral pacemaker: a single-center series performed with an easier and safer surgical technique.
Pace, (2005), 28 pp. 675-679
[36.]
M.H. Ellestad, R. Caso, P.S. Greenberg.
Permanent pacemaker implantation using the femoral vein: a preliminary report.
Pace, (1980), 3 pp. 418-423
Copyright ©
2007. Sociedad Española de Cardiología